[1]
V. A. Rajadnya and S. R. Bedi, “Cost comparisons of five leading brands of the antihypertensive drug, Telmisartan, available in an Indian city”, Int J Basic Clin Pharmacol, vol. 8, no. 6, pp. 1377–1380, May 2019.